Online Program Home
  My Program

Keyword Search

Legend:
CC = Baltimore Convention Center,    H = Hilton Baltimore
* = applied session       ! = JSM meeting theme

Keyword Search Criteria: toxicity returned 9 record(s)
Sunday, 07/30/2017
Basket Trial Considerations in Phase Ib/IIa Oncology Studies of Targeted Therapy
Yihua Zhao, Boehringer Ingelheim Pharmaceuticals, Inc.
4:45 PM

Monday, 07/31/2017
A Bayesian Adaptive Design in Cancer Phase I Trials Using Dose Combinations with Ordinal Toxicity Grades
Sungjin Kim, Cedars-Sinai Medical Center; Marcio Diniz, Cedars Sinai Medical Center; Mourad Tighiouart, Cedars-Sinai Medical Center


Drug Combination Dose Allocation Using Minimal Sets and Coherence in Partially Ordered Sets in Phase I Cancer Trials
Galen Cook-Wiens, Cedars Sinai Medical Center; Matthieu Clertant, Cedars-Sinai Medical Center; Mourad Tighiouart, Cedars-Sinai Medical Center


Design of Drug Combination Early Phase Cancer Trials Using Time to Toxicity Data
Marcio Diniz, Cedars Sinai Medical Center; José Jimenez, Politecnico di Torino; Andre Rogatko, Cedars Sinai Medical Center; Mourad Tiguiouart, Cedars Sinai Medical Center


A Latent Variable Approach to Elicit Continuous Toxicity Scores and Severity Weights for Multiple Toxicities in Dose-Finding Oncology Trials
Nathaniel O'Connell, Medical University of South Carolina; Elizabeth Garrett-Mayer, Medical University of South Carolina
2:05 PM

Tuesday, 08/01/2017
Dose Finding in Oncology Trials: a Discussion on Challenges and Current Methods
Zhao Yang, Amgen, Inc.


Wednesday, 08/02/2017
Bayesian Design for Interim Analysis
Dung-Tsa Chen, Moffitt Cancer Center
9:20 AM

Thursday, 08/03/2017
Design of Phase I/II Drug Combination Cancer Trials Using CRM and Adaptive Randomization
Mourad Tighiouart, Cedars-Sinai Medical Center; Matthieu Clertant, Cedars-Sinai Medical Center
9:20 AM

Modeling and Simulation to Detect Unusual Patterns in Genotoxicity Data (Microbial Assays)
Elena Rantou, FDA/CDER
10:35 AM

 
 
Copyright © American Statistical Association